Andrew Li, MD

Co-Director, Women's Reproductive Cancers Center, Cancer Institute
Fax:(310) 423-0155

Institute Affiliation

Cancer Institute

Academic Appointments

Associate Clinical Professor, OBGYN
Assistant Professor, Obstetrics and Gynecology

Awards and Activities

APGO/CREOG Teaching Award2010
Top Reviewer, Gynecologic Oncology2010
Golden Apple Teaching Award2009
UCLA Medical Student Teaching Award2009
Golden Apple Teaching Award2005
Golden Apple Teaching Award2003
National Cancer Institute Scholarship: American Assoc Cancer Research, Am Society Clin Oncology2002
Clinical Scholar's Award: American Association of Cancer Research2002
Scholar-in-Training Award: American Association of Cancer Research2001
Outstanding Research Presentation: SmithKlineBeecham Gynecologic Oncology Fellows' Forum2000
Editor: Gynecologic Oncology: Clinical Practice and Surgical AtlasCurrent
Reviewer: OncogeneCurrent
Reviewer: American Journal of Obstetrics and GynecologyCurrent
Reviewer: Obstetrics and GynecologyCurrent
Reviewer: Cancer ResearchCurrent
Reviewer: Clinical Cancer ResearchCurrent
Reviewer: Gynecologic OncologyCurrent
American College of Obstetrics and Gynecology1995
American Association for Cancer Research1999
Society of Gynecologic Oncologists (SGO)1999
Western Association of Gynecologic Oncologists2005

Research Focus

Influence of molecular and lifestyle factors on epithelial ovarian cancer biology. Specifically, examining the influence of obesity, statin use, and cigarette smoking on survival, and also studying molecular mechanisms in aberrant androgen receptor signaling in malignant ovarian cell cultures.

Research Contributions

Established the interaction between androgen receptor polymorphisms and epidermal growth factor receptor signaling in ovarian cancers; identified significant correlations between obesity and statin use as factors in ovarian cancer survival.

Current investigations include:

Determining the molecular mechanisms by which statins influence aggressive ovarian cancer biology.

Selected Publications

  1. Pavelka JC, Brown RS, Karlan BY, Cass I, Leuchter RS, Lagasse LD, Li AJ: Effect of obesity on survival in epithelial ovarian cancer. Cancer, 107(7): 1520-4, 2006
  2. Li AJ, Scoles DR, Armstrong KU, Karlan BY: Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas. Gynecol. Oncol., 109(2): 220-5, 2008
  3. Li AJ, Karlan BY: Androgen mediation of thrombocytosis in epithelial ovarian cancer biology. Clin. Cancer Res., 11(22): 8015-8, 2005
  4. Li AJ, Elmore RG, Pavelka JC, Karlan BY: Hyperandrogenism, mediated by obesity and receptor polymorphisms, promotes aggressive epithelial ovarian cancer biology. Gynecol. Oncol., 107(3): 420-3, 2007
  5. Li AJ, Lerner DL, Gapuzan ME, Karlan BY: AIB1 polymorphisms predict aggressive ovarian cancer phenotype. Cancer Epidemiol. Biomarkers Prev., 14(12): 2919-22, 2005
  6. Li AJ, Baldwin RL, Karlan BY: Short androgen receptor allele length is a poor prognostic factor in epithelial ovarian carcinoma. Clin. Cancer Res., 9(10 Pt 1): 3667-73, 2003
Android app on Google Play